ISAR-DIABETES: Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent for the Prevention of Restenosis in Diabetic Patients with Coronary Artery Disease
1Alban D, Adnan K, Julinda M, et al. Paclitaxel-eluting stent versus Sirolimus-eluting stcnt for the prevention of restenosis in diabetic patients with coronary artery disease [J]. N Engl J Med,2005,53 : 663-670.
3O'Brien RG, Muller KE, Unified power analysis for t-test through multivariate hypotheses [M] //Edwards LK,ed. Applied analysis of variance in behavioral science, New York: Marcel Dekker, 1992.
1Giannakakou P,Roby R,Fojo T,et al. Low concentration of peclitaxel induce cell type dependent p53,p21 and G1,G2 arrest in stead of mitotic arrest: molecular determinants of paclitaxel induced cytotoxicity[J]. Oncogene,2001,20:3806-3813.
